Multiple Myeloma’s Link To Round-Up Weed Killer | We Are Talking To Victims Like You
For decades, Round-up has been used by homeowners across the United States to kill unwanted weeds in their yards. Unfortunately, a grim reality related to Round-up has recently come to light. Glyphosate, the main ingredient in Round-up, is the most popular and profitable agrochemical, being registered to use in over 160 countries and accounting for around 25% of the global herbicide market. Recently a California jury voted to penalize Monsanto/Bayer 2 billion dollars for their deceit and fraudulent marketing of Round-Up.
Multiple Myeloma is a form of cancer that begins in plasma cells, typically found in bone marrow. These cells are critical to making the antibodies necessary to fight off infections. Myeloma cells can cause a myriad of complications, including tumors that grow inside a bone, brittle bones that lead to breakage susceptibility, likeliness for severe infections, and kidney or heart failure. Patients who have been diagnosed with this form of cancer often need radiation, chemotherapy, or targeted therapy that is aimed at specific cancer cells.
Glyphosate
In a 2019 study, published in the Journal of Hematology and Oncology, Cleveland Clinic oncologists found Glyphosate to be an environmental risk factor for the development of multiple myeloma in animal studies. Further, the data established an implication that the mechanism underlying the B cell-specificity of glyphosate-induced carcinogenesis which were observed in epidemiological studies. These authors reviewed the varied epidemiological study results as well as the contradictory animal studies about the relationships of Glyphosate with multiple myeloma. They concluded the third pillar, required to define a compound, as a carcinogen mechanism of action had not been established before their study. Their study date revealed that mechanism. Glyphosate elicits B cell-specific mutational mechanism action in promoting carcinogenesis. This finding provides a molecular basis for the epidemiological studies linking Glyphosate to the development of multiple myeloma.
Why Hire Brock & Goetzmann?
If you have been diagnosed with multiple myeloma as a result of Round-Up use, the skilled legal team at Brock & Goetzmann is a committed injury law firm with proven results. We are accepting cases from Round-Up related multiple myeloma victims and their families. It has been reported Monsanto/Bayer is currently exploring settlement of all Round-up cases. With over 50 years of combined legal experience, Brock & Goetzmann can effectively represent your interests. To schedule a consultation with a legal team who cares, contact Brock & Goetzmann today.
Wang, L, et al., Glyphosate induces benign monoclanal gammopathy and promotes multiple myeloma progression in mice. Journal of Hematology & Oncology, (2019)12:70, available at https://doi.org/10.1186/s13045-019-0767-9
